Clinical Trial Update: Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing GSK134612 in individuals previously vaccinated against meningococcal disease to non-vaccinated individuals; results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• GSK134612 (Meningococcal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED | Results posted: 2018-12-28